TrialKey

Clinical research consulting

Better clinical-trial decisions, supported by AI and human expertise.

TrialKey provides AI-enabled clinical research consulting for pharmaceutical, biotechnology and medtech sponsors. Combine clinical-development expertise, historical evidence and predictive modelling to decide what to develop, how to study it and how to manage the risks that matter.

Sponsor-side support from asset strategy through live study oversight

Consulting pathway

One question. Connected decisions.

01
Define the programme decision
02
Ground it in relevant evidence
03
Model risks and alternatives
04
Apply expert judgement
05
Recommend the next action

Decision-ready output: an evidence-grounded recommendation, supported alternatives and a practical action plan.

Why teams seek support

What are you trying to decide?

Clinical research consulting is rarely one isolated task. Most teams need a connected answer across strategy, protocol design, feasibility and execution.

Plan the development programme

Prioritise indications, sequence studies and define the evidence, regulatory, operating and capital plan around an asset.

Design or improve a clinical trial

Develop a study concept, write the synopsis and protocol, or pressure-test eligibility criteria, endpoints, sample size, visit burden, duration and feasibility.

Assess feasibility and probability of success

Benchmark a proposed study against historical evidence, identify material risks and compare better-supported alternatives.

Strengthen trial execution

Select countries, sites, CROs and partners, then monitor recruitment, quality, cost, timelines and emerging delivery risk.

Practical research support

From study concept to submission-ready documents.

Some engagements require a strategic answer. Others need experienced hands to turn that answer into the clinical research documents and submissions that move the study forward.

01

Study synopsis writing

Turn the development concept and evidence into a clear synopsis covering objectives, population, treatment, endpoints, assessments and analysis assumptions.

02

Clinical trial protocol writing

Develop a new clinical trial protocol or strengthen an existing draft so the scientific rationale, design choices and operating requirements are coherent.

03

Ethics, HREC and IRB submissions

Prepare and coordinate ethics submission packages, responses and supporting materials for the relevant human research ethics committee or institutional review board.

04

Participant and consent materials

Draft or review participant information sheets, informed consent forms and study-facing materials for clarity, consistency and submission readiness.

05

Protocol amendments and responses

Assess the implications of requested changes, update affected study documents and support responses to ethics, regulatory or stakeholder questions.

06

Research governance and start-up support

Structure the document plan, responsibilities, review pathway and submission sequence needed to move from study concept toward activation.

Need a combination of clinical development consulting, protocol writing and ethics submission support? TrialKey can define one integrated work plan around the study and sponsor responsibilities.

Discuss the scope

The TrialKey model

Technology expands the analysis. Experts own the recommendation.

TrialKey's consulting model combines a larger evidence base and more systematic scenario analysis with the clinical judgement needed to turn results into a practical decision.

AI and modelling

Search a wider decision space

  • Find relevant historical trial patterns
  • Rank influential design and execution variables
  • Simulate alternatives within programme constraints
  • Make assumptions and trade-offs visible

Human expertise

Turn evidence into action

  • Challenge data quality and model assumptions
  • Apply clinical, regulatory and operational context
  • Reject options that are impractical or unsafe
  • Recommend an executable path forward

570,000+

Clinical trials analysed

100,000+

Simulations per assessment

1,500+

Variables curated per trial

Consulting outputs

Evidence your team can use.

The output is shaped around the decision and its audience—from a focused study-team recommendation to an integrated development plan or board-ready investment paper.

01

A clear definition of the decision, assumptions and constraints

02

A focused evidence review using relevant clinical-trial precedents

03

Modelled scenarios, alternatives and material risk drivers

04

Expert interpretation of what the evidence means for the programme

05

A prioritised recommendation with actions, owners and decision points

06

Board, investment-committee or study-team-ready decision material

Questions

Clinical research consulting FAQs

What does a clinical research consultant do?+

A clinical research consultant helps sponsors make scientific, statistical, operational and governance decisions across the clinical-development pathway. Depending on the question, this can include development strategy, study design, protocol development, feasibility, country and site selection, competitive analysis, CRO selection or study oversight.

How is TrialKey's clinical research consulting different?+

TrialKey combines experienced clinical-development and operations input with structured historical trial evidence, machine learning, simulation and AI-assisted analysis. The technology expands and tests the available options; subject-matter experts interpret the results and remain responsible for the recommendation.

Can TrialKey help before a protocol exists?+

Yes. An engagement can begin with an asset, indication and treatment type, a development concept, a draft study plan, a synopsis or an existing protocol. The starting material determines which questions and evidence sources are prioritised.

Does TrialKey replace a CRO or regulatory adviser?+

No. TrialKey can complement specialist regulatory advisers, statisticians, medical writers and CRO delivery teams. It provides integrated decision support and, where required, an independent sponsor-side view of evidence, assumptions, options and execution risk.

Can TrialKey support protocol writing and ethics submissions?+

Yes. TrialKey can support study synopsis and clinical trial protocol writing, protocol amendments, participant information and informed consent materials, and preparation or coordination of ethics, HREC and IRB submission packages. The exact scope is agreed for the study, jurisdiction and responsible sponsor team.

Who is the service designed for?+

The service is designed for pharmaceutical, biotechnology and medtech sponsors, clinical-development teams, boards, investors and CRO partners making decisions about an asset, study or live programme.

Start with the decision

Discuss your clinical research programme.

Bring us the asset, study or programme decision you need to make. We will show how TrialKey can structure the evidence, test the alternatives and define the first useful deliverable.